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We describe a general application of the nonsense suppression
methodology for unnatural amino acid incorporation to probe drug–
receptor interactions in functional G protein-coupled receptors
(GPCRs), evaluating the binding sites of both the M2 muscarinic
acetylcholine receptor and the D2 dopamine receptor. Receptors were
expressed in Xenopus oocytes, and activation of a G protein-coupled,
inward-rectifying K channel (GIRK) provided, after optimization of
conditions, a quantitative readout of receptor function. A number of
aromatic amino acids thought to be near the agonist-binding site
were evaluated. Incorporation of a series of fluorinated tryptophan
derivatives at W6.48 of the D2 receptor establishes a cation– inter-
action between the agonist dopamine and W6.48, suggesting a
reorientation of W6.48 on agonist binding, consistent with proposed
‘‘rotamer switch’’ models. Interestingly, no comparable cation–
interaction was found at the aligning residue in the M2 receptor.
D2 receptor  fluorination  membrane protein
G protein-coupled receptors (GPCRs) represent the largestfamily of transmembrane receptor proteins in the human
genome and constitute a prominent class of targets for the phar-
maceutical industry (1–3). Accordingly, they have been studied
extensively throughout academia and industry, by using the full
range of chemical, biochemical, and biophysical techniques. In
recent years, the field has been energized by several high-resolution
crystal structures ofmammalianGPCRs that build upon the earlier,
highly informative structural studies of rhodopsin and bacteriorho-
dopsin (4–9).
The structural snapshots provided by crystallography greatly
enhance our understanding of specific receptors but also raisemany
new issues. Key among these is the extent to which the information
from available structures can be extrapolated to the hundreds of
other GPCRs. In addition, a key goal in the study of GPCRs—and
all receptors—is a description of the interconversions among
several structural states that underlie the protein’s biological
function. It can be a challenging task to deduce a signaling
mechanism from static images. As such, structure–function
studies, guided by the new structural advances, will remain an
important tool in evaluating GPCR function and the nature of
drug–receptor interactions in this family.
In recent years, unnatural amino acid mutagenesis on ion chan-
nels and receptors expressed in Xenopus oocytes has provided a
powerful tool for uncovering crucial drug–receptor interactions and
signaling mechanisms (10, 11). GPCRs present an especially at-
tractive target for unnatural amino acid mutagenesis, given the
importance of the family, the significant pharmacological variations
among closely related family members, and the central role of
structural rearrangements in their biological function.
Incorporating unnatural amino acids into GPCRs, however,
presents unique challenges. Most unnatural amino acid mutagen-
esis studies in eukaryotic cells have focused on ion channels. These
studies exploit the exquisite sensitivity of electrophysiology, which
allows for detailed characterization even when only small quantities
of protein are produced, as is often the case with unnatural amino
acidmutagenesis. BecauseGPCRs are not ion channels and instead
produce downstream signals through second messenger systems, a
direct readout of GPCR activation during an unnatural amino acid
experiment is not possible.
In the present work, we describe a general strategy for chemical-
scale studies of GPCRs using unnatural amino acid incorporation
in a vertebrate cell. Electrophysiology again provides the functional
readout, through downstream activation of a K channel. We also
report studies of key aromatic amino acids in the agonist-binding
region of the M2 muscarinic acetylcholine (ACh) receptor and the
D2 dopamine receptor. We found that W6.48, a residue long
postulated to play an important role in signaling, makes a cation–
interaction to dopamine in the active state of the D2 receptor.
Interestingly, ACh does not make the same interaction to the
conserved W6.48 of the M2 receptor.
Results
Optimization of a GPCR Readout System.Wehavedeveloped a robust
assay for studying GPCRs containing unnatural amino acids ex-
pressed in Xenopus oocytes. Key issues are described here; full
details can be found elsewhere (12).
We began with an established readout system based on a G
protein-coupled, inward-rectifying K channel (GIRK). Upon ac-
tivation of a Gi/o-coupled receptor, G subunits dissociate from
the GPCR and then bind to and activate the GIRK channel; G
subunits also alter channel activation (13–16). This is themost direct
known pathway from a GPCR to a channel, providing, in principle,
a straightforward electrophysiological assay for GPCR activation.
Fig. 1 illustrates the basic protocol. The basal K current (IK,Basal)
results primarily from the presence of free intracellular G (17,
18). The agonist-induced current (IK,Agonist) is measured relative to
the basal K current. Both basal and agonist-induced currents are
measured in the presence of a high K concentration (24 mM),
which provides appropriately large K currents at a modest holding
potential (60 mV).
The challenge in implementing this system was to ensure that
dose–response relationships provided direct assays of GPCR acti-
vation. To yield reproducible data, we optimized the assay system,
primarily in experiments with expressed M2 receptors. In previous
studies, RGS proteins were shown to accelerate the deactivation
kinetics of GIRK currents via G-mediated GTP hydrolysis, while
also increasing the activation rates of GIRK currents (18–20).
Coexpression of RGS4 did indeed result in faster activation and
deactivation kinetics in IK,Agonist traces.
We also experimented with coinjection of GoA mRNA. The
added GoA could bind endogenous G, and thus minimize
IK,Basal, another source of variability. Although this coinjection did
suppress basal currents, it also produced aberrant shifts in EC50 (SI
Text). We therefore abandoned GoA mRNA coinjections.
The nonsense suppression methodology can yield low levels of
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expression for the protein of interest, and thus weak agonist-
induced GIRK1/GIRK4 signals. To increase expression levels for
theM2 receptor, we used 2 injections of suppressor tRNA. The first
injection occurred 48 h before recording and included the amino-
acyl-tRNA, along with the M2 receptor and GIRK mRNAs. The
second tRNA injection, alongwith theRGS4mRNA, occurred 24 h
before the assay.We evaluated this protocol on 2mutants in theM2
receptor: W6.48Trp and W7.40Trp. In nonsense suppression ex-
periments, we list the wild-type residue in one-letter code, the
location using the X.50 nomenclature system (Fig. S2) (21), and
then the amino acid appended to the tRNA.These experiments are,
thus, wild-type ‘‘recovery’’ by nonsense suppression. In both cases,
a second injection of tRNA led to larger IK,Agonist: 67% and 89%
increases for W6.48 and W7.40, respectively.
Considerable variability was seen from oocyte to oocyte in
single-cell EC50 values (cEC50), as quantified by the coefficient of
variation (CV) (22). On varying the ratio of mutant M2 receptor to
GIRK1/GIRK4 mRNAs, by using ratios of 0.4, 1.0, 2.0, and 4.0, a
strong correlation (R 0.98) between themRNA ratio and the CV
was seen, with smaller ratios producing smaller CVs. Although the
mRNA ratio of 0.4 gave the least variability, the expression effi-
ciency was quite low and irregular, and other studies showed that
EC50 variability increased when current was small (Fig. S1). We
therefore chose an M2/GIRK mRNA ratio of 1.0 (10 ng of M2
receptor mRNA and 10 ng of GIRK mRNA). In 7 different
nonsense suppression experiments, these conditions gave cEC50
CVs that ranged from 0.28 to 0.52, which are adequate for
meaningfully interpreting variations in EC50 among mutants. The
equivalent CV for conventional mutagenesis was 0.55.
The nonsense suppression studies of the M2 receptor were thus
conducted as follows. Forty-eight hours before recording we in-
jected 10 ng of the stop codon mutant M2 mRNA, 10 ng each of
GIRK1 and GIRK4 mRNA, and 25 ng of the suppressor tRNA
ligated to the amino acid of choice. Twenty-four hours later, we
injected an additional 25 ng of aminoacyl-tRNA and 10 ng of RGS4
mRNA.
In theD2 receptor system, IK,Agonist levels were consistently lower
than those for the M2 receptor, prompting the use of a different
mRNA ratio. Adequate expression in the D2 system was achieved
by increasing the amount of D2 receptor mRNA and suppressor
tRNA 4-fold. Perhaps because of the lower expression levels,
including RGS4 affected response waveforms only weakly. Thus,
conditions used for D2 receptor experiments were: 40 ng of stop
codon mutant D2 receptor mRNA, 10 ng each of GIRK1 and
GIRK4 mRNA, and 100 ng of suppressor tRNA 48 h before
recording. Twenty-four hours later, we injected an additional 100 ng
of aminoacyl-tRNA. These conditions resulted in adequate GIRK
currents and in cell-to-cell CVs ranging from 0.21 to 0.46.
Nonsense Expression Experiments. The binding region of class A
GPCRs, such as theM2 andD2 receptors, is rich in aromatic amino
acids (Fig. 2) (4–8, 23). Both ACh and dopamine have charged
ammonium groups, suggesting the possibility of a cation– inter-
action (24, 25). In the Cys-loop family of ligand-gated ion channels,
ACh and serotonin (which bears structural similarities to dopa-
mine) make cation– interactions to a conserved Trp in the
nicotinic (26, 27) and the 5-HT3 receptors (28), respectively.
The nonsense suppression protocol for identifying a cation–
interaction is well-established. If a cation– interaction between the
agonist and the particular aromatic is essential, progressive fluori-
nation of the aromatic amino acid steadily diminishes the affinity of
the drug for the binding site. To probe a potential cation–
interaction at a Trp site, the appropriate unnatural amino acids are
5-F-Trp (F1Trp); 5,7-F2-Trp (F2Trp); 5,6,7-F3-Trp (F3Trp); 4,5,6,7-
F4-Trp (F4Trp); and 1-napthylalanine (Nap) (Fig. 3). At a Phe site,
the appropriate analogues are 4-F-Phe (F1Phe); 3,5-F-Phe (F2Phe);
3,4,5-F-Phe (F3Phe); 4-methyl-Phe (MePhe); 4-cyano-Phe
(CNPhe); 4-bromo-Phe (BrPhe), 3,5-dimethyl-Phe (Me2Phe); and
cyclohexylalanine (Cha).
In the M2 receptor, 3 Trp residues were studied: W3.28, W6.48,
24 mM K+ agonist ND96
IK, basal
IK, agonist
(a)
(b)
(c) 500 nA
20 s
Fig. 1. Exemplarcurrent tracesduringaGPCRvoltage-clampexperimentonthe
D2receptor.Agonist concentrationwas10Mdopamine. IK, Basal isdefinedas the
current difference between b and a; subtraction of b from c yields IK, Agonist
 3.28 
5.47
6.48
6.51
6.52
3.32
7.40
Fig. 2. An image of the 2 structure [Protein Data Bank (PDB) ID code 2RH1]
with the residues considered here highlighted. Helix 3 is blue; helix 6 is purple.
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Fig. 3. Structures of unnatural amino acids used in this study.
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and W7.40 (Fig. 2). At W6.48 and W7.40, fluorination studies
produced no consistent trends (Fig. 4A and Table 1). Most impor-
tantly, F3Trp produced an EC50 value very near that of wild-type at
both W6.48 and W7.40. These data rule out any possibility of a
strong cation– interaction.
Studies of W3.28 in the M2 receptor were problematic. When
we injected mutant mRNA and full-length tRNA without an
appended amino acid, we observed IK,Agonist values that were
substantially larger than what is typically seen in this essential
control experiment. As such, W3.28 is presently an uninforma-
tive site for studies using nonsense suppression with the amber
suppressor THG73 tRNA. We were able to determine an EC50
value of 1,900 nM for currents created in this experiment, a
10-fold increase over wild type.
Five different aromatic amino acids were evaluated in the D2
receptor (Fig. 2 and Table 1). F3.28 and F5.47 were quite
tolerant of substitution. The largest structural perturbation
introduced—Cha—gave essentially wild-type behavior. In sharp
contrast, F6.51 and F6.52 were very sensitive to substitution. The
primary factor appears to be sterics, with larger substituents
producing larger effects.
Incorporation of fluorinated tryptophans at W6.48 resulted in
systematic increases in EC50, with 2.8-, 6.9-, 20-, and 43-fold shifts
in the series from 1 to 4 fluorines. The standard plot of the
calculated gas-phase cation– binding energies against log EC50
gave the hallmark linear relationship of a cation– interaction. (Fig.
4 B and C)
The electron-withdrawing ability of a fluorine attached to an
indole ring would also be expected to diminish the hydrogen-
bonding ability of the indole NH. If a hydrogen bond to this indole
NH were essential to receptor function, a linear fluorination plot
could also arise. To test for a hydrogen-binding effect, we removed
any possibility of such a hydrogen bond by incorporating the
unnatural amino acid Nap, which is sterically very similar to Trp
but lacks the NH. The modest shift caused by the Nap mutation
(Table 1) rules out an essential hydrogen-bonding role for the
indole NH of W6.48, especially in contrast with the much larger
43-fold shift for F4Trp, which has the indole NH. Note that Nap
is a weaker cation– donor than Trp (26), consistent with the
modest rise in EC50.
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Fig. 4. Fluorinationplots anddose-response curves. (A) FnTrpdata for theM2receptoranalyzed in termsofgasphase cation–bindingenergiesoffluorinated indole
rings vs. the log of the ratio of the FnTrp EC50 and wild-type EC50. Dashed line, W7.40; solid line, W6.48. (B) Fluorination plot as in A for W6.48 of the D2 receptor. (C)
Dose–response relations for W6.48 of the D2 receptor; EC50 values plotted in B.
Table 1. EC50 values (M), with SEM values in parentheses
Site Residue EC50 Site Residue EC50
M2 receptor
W3.28 –* 1,900 (80) W7.40 Trp 190 (20)
W6.48 Trp 310 (6) F1Trp 240 (9)
F2Trp 1,100 (70) F2Trp 1000 (80)
F3Trp 420 (30) F3Trp 170 (10)
D2 receptor
F3.28 Phe 55 (1) W6.48 Trp 42 (4)
F1Phe 140 (10) F1Trp 120 (10)
F2Phe 36 (1) F2Trp 290 (30)
F3Phe 140 (10) F3Trp 840 (60)
Cha 97 (2) F4Trp 1,800 (300)
F5.47 Cha 78 (1) Nap 190 (20)
F6.51 Phe 64 (4) F6.52 Phe 45 (3)
F1Phe 76 (6) F1Phe 41 (2)
F2Phe 4,200 (350) F2Phe 1,700 (100)
F3Phe 6,200 (400) F3Phe 5,500 (400)
CNPhe 1,340 (160) CNPhe 240 (30)
MePhe 690 (40) MePhe 91 (6)
Me2Phe 75,000 (5,000) Me2Phe 33,000 (3,000)
Cha 55,000 (4,000) BrPhe 1,500 (100)
Hill coeffiecients generally range from 0.9 to 1.1; number of cells is generally 7. Full data are given in Table S1.
*Experiment with unacylated tRNA.
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Discussion
In the present work, we have developed a general protocol to
prepare and functionally characterizeGPCRs containing unnatural
amino acids.Wehave applied themethodology to both theM2ACh
receptor and the D2 dopamine receptor. In this initial study, we
have identified a distinctive cation– interaction between dopa-
mine andW6.48, a residue that has been proposed to play a key role
in receptor function.
Unnatural Amino Acid Mutagenesis at GPCRs.Given the broad range
of structures and activities for GPCRs, as well as their undeniable
pharmaceutical importance, it has been appreciated for some time
that unnatural amino acids could provide a valuable probe of this
essential class of membrane receptors. An early study incorporated
the fluorescent unnatural amino acid NBD-Dap into the NK2
receptor and showed that exposure to tachykinin did produce
measurable electrophysiological currents in Xenopus oocytes (due
to opening of Ca2-activated Cl channels that are endogenous to
the oocyte) (29). A very recent study used an orthogonal tRNA–
synthetase pair to incorporate a benzophenone-containing unnat-
ural amino acid into the Ste2p GPCR (30) and the CCR5 receptor
(31). Certainly, extensive conventional mutagenesis studies on
GPCRs have provided a wealth of valuable information about
which residues are important to receptor function (32). However,
the more subtle variations that are possible with the unnatural
amino acid methodology can provide additional insights into the
precise role of a given residue.
Here, we describe a general application of nonsense suppression
methodology to GPCRs, incorporating 13 different unnatural
amino acids and developing a reliable readout system that can be
used in chemical-scale studies ofmanyGPCRs.Our initial focus has
been on the M2 muscarinic ACh receptor and the D2 dopamine
receptor. These are class A GPCRs, a group that also includes
adrenergic, serotonin, odorant, peptide, and glycoprotein hormone
receptors. The binding site in this class lies within a crevice formed
by several of the transmembrane helices and includes the highly
conserved Asp 3.32 (Fig. 2). In addition, it has long been appre-
ciated that a cluster of aromatic amino acids shapes much of the
binding crevice, and recent structural studies positionmany of them
in locations that could be expected to contribute to agonist and
antagonist binding.
We chose the M2 and D2 receptors for this initial study partly
because they both couple to the Gi/o pathway, which gates GIRK
channels, along with inhibiting adenylate cyclase. GIRK channels
provide a sensitive readout of GPCR activation, a critical feature
given the often small quantities of protein made by nonsense
suppression. However, the use of a downstream signal added
significant complications to the process, compared with our previ-
ous nonsense suppression studies on ion channels. We can readily
control the expression levels of some of these proteins, such as
GIRK, but it is less straightforward to control others, such as the
G protein and the GPCR itself, when incorporating unnatural
amino acids. In addition, other cellular pathways can intersect
with the desired signaling pathway in unanticipated ways. For-
tunately, we found conditions to minimize this variability; vari-
ations in EC50 reported in this study are meaningful to a
confidence level of 99% (12).
After controlling for adequate expression efficiencies and con-
sistent dose–response relationships, we arrived at optimum condi-
tions for the M2 and D2 receptor systems. RSG4 expression was
used in the M2 system to provide more uniform, faster electro-
physiological responses. The delayed injection of RGS4 mRNA
produced more consistent expression of the RGS protein, as
observed through changes to trace kinetics. We believe that this
delay in injection provides the cell’s translational and membrane-
trafficking machinery a chance to process the M2 and GIRK
mRNAs before expressing theRGS4 protein. In addition, relatively
low ratios of M2 to GIRK1/GIRK4 mRNA were necessary. We
consider these ratios low because the typical expression efficiency
of the nonsense suppression methodology is roughly 10% that of
conventional expression. Thus, a 1:1 ratio of M2 to GIRK1/GIRK4
mRNA could be considered to produce a 0.1:1 ratio of proteins.
Presumably, the rather low GPCR expression levels minimize the
possibility that receptor activation saturates G proteins, GIRK
channels, or other downstream elements in the signaling pathway,
whichwould distort the dose–response relations. Injecting cells with
wild-type recovery conditions alongside cells with mutant condi-
tions provided an additional means to assess the variability of a
given batch of cells.
Interactions at GPCR-Binding Sites. This initial study focused on
several aromatic amino acids in or near the agonist-binding site.
W(F)3.28 was chosen because of its position 4 amino acids—
approximately 1 turn of an -helix—above the highly conserved
D3.32. If the cationic moiety of the agonist makes an electrostatic
(ion pair) interaction with D3.32, then W(F)3.28 could be well
positioned to augment the binding. W6.48 is highly conserved
throughout the classAGPCRs and has been proposed to be in close
proximity to the agonist-binding site and to play a central role in
receptor activation (9, 33). In particular, binding-induced changes
in the rotameric state of W6.48 are thought to act as part of a
‘‘switch’’ that is critical to receptor function (4, 9, 33–37). W7.40 is
the next most highly conserved residue associated with the amin-
ergic class ofGPCRs (38). F6.51 andF6.52were chosen because the
rhodopsin and2AR structures place them in close proximity to the
agonist. Previous studies on the D2 receptor and other aminergic
GPCRs have shown that mutations to these helix 6 residues have
substantial effects on agonist affinity (32, 39).
The most compelling results are seen for W6.48 of the D2
receptor. A clear linear correlation is seen in the ‘‘fluorination plot’’
(Fig. 4B), establishing a cation– interaction. By using the 2
structure as a guide (5, 7), one finds no cationic residues (Lys/Arg)
within 8 Å ofW6.48. Thus, we propose that dopamine contains the
cationic moiety forming the cation– interaction with W6.48. This
establishes an energetically significant cation– interaction be-
tween dopamine and W6.48 of the D2 receptor.
The fluorination strategy used here has been used previously to
identify cation– interactions in 8 different Cys-loop receptors for
4 different monoamine neurotransmitters (10). These studies have
led to the conclusion that the slope of a fluorination plot is related
to the energy of the cation– interaction. Primary ammonium ions
(RNH3), such as those in serotonin and GABA, produce larger
slopes than the quaternary ammonium ion [RN(CH3)3] of ACh.
Studies have established that a cation– interaction is intrinsically
stronger for the smaller, higher-density charge of primary ammo-
nium ions vs. quaternary ammonium ions (40, 41).
In the D2 receptor, the fluorination plot for W6.48 has a slope
of 0.092, which is smaller thanwould be expected for an agonist with
a primary ammonium group. For example, the primary ammonium
of serotonin interacts with Trp-183 in the 5-HT3 receptor with a
fluorination slope of 0.17 (28). The value for dopamine is much
closer to that measured for the interaction between the quaternary
ammonium of ACh and a Trp of the nAChR (0.096) (26). This
suggested an alternative type of cation– interaction for dopamine.
Despite the typically used symbolism (R4N), the positive charge of
an alkylated ammonium group is not focused on the nitrogen, but
rather on the directly attached hydrogens or alkyl groups. The CH2
group adjacent to the ammonium of dopamine (the -methylene
carbon) carries a significant positive charge, one that is similar to
that of the methyl groups on the quaternary ammonium of ACh
(Fig. 5). Based on the similarity of the slopes for the fluorination
plots for dopamine and ACh (in the nAChR), we propose that it is
the -methylene group rather than the ammonium group on
dopamine that forms a cation– interaction with W6.48. Such a
cation– interaction is, in fact, quite common. In a previous survey
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of cation– interactions that stabilize protein secondary structure,
for energetically significant cation– interactions involving lysine
[i.e., Lys(Phe,Tyr,Trp)], most structures involved the  carbon of
lysine contacting the face of the aromatic ring (42).
A binding orientation in which the -methylene carbon of
dopamine forms a cation– interaction would leave the ammonium
group free to hydrogen bond/ion pair with the highly conserved
D3.32. A geometry such as that of Fig. 6 seems quite plausible. A
prominent role in binding for D3.32 is well-established in several
GPCRs (32, 43), and in the present work we found that D3.32E and
D3.32N produced 1,000- and 3,000-fold shifts in dopamine EC50,
respectively. Our data thus suggest that helices 3 and 6 jointly
interact with the OCH2ONH3 group of dopamine.
Implications for the Rotamer Switch Mechanism at W6.48. The joint
interaction of theOCH2ONH3 group with helices 3 and 6 agrees
with the contemporary model for receptor activation that has the
extracellular portion of helix 6 moving toward helix 3. This move-
ment of helix 6 is part of a rotamer switch activation mechanism (4,
9, 33–37). A key component of this model is a reorientation of the
side chain of indole of W6.48 from a perpendicular to a parallel
orientation, relative to the plane of the membrane, as the receptor
transitions from the inactive to active state. This conformational
change is associated with straightening of a proline kink in helix 6
and movement of the extracellular portion of helix 6 toward
helix 3.
In a simple docking of dopamine into the 2 receptor structure,
it is not possible to make the ion pair interaction to D3.32 and the
cation– interaction to W6.48 simultaneously. In this structure, a
presumed inactive form of the receptor (7), the indole side chain is
in the perpendicular orientation (Fig. 2). We found that rotation of
the indole side chainwith no further relaxation of the structure does
allow formation of both the ion pair and the cation– interaction,
as shown in Fig. 6. Thus, we propose that a key component of the
rotamer switch mechanism in the D2 receptor is a reorientation of
the side chain of W6.48 so that a cation– interaction can form to
the -carbon on dopamine. This is consistent with the fact that
dose–response relationships for receptor function are rightward-
shifted with successive fluorination (Fig. 4C), suggesting that
dopamine andW6.48 interact more strongly while the receptor is in
the active, functional state.
Other Residues. The present data show that 2 other aromatic amino
acids of the D2 receptor—F6.51 and F6.52—do not make a
cation– interaction but are very sensitive to substitution. Data
from the monosubstituted Phe derivatives suggest the sensitivity is
at least in part due to a steric interaction more than an electronic
effect. For F6.51, F1Phe is essentially wild type, but MePhe is
significantly perturbed. Methyl is sterically larger than fluorine but
has essentially no electronic impact when compared to the electron-
withdrawing fluorine. For F6.52, an electronic effect can be ruled
out, because the magnitude of the EC50 shift for the Br analog is
larger than that of the cyano analog, which is the reverse of their
electron-withdrawing effects. Recent structural data for the -ad-
renergic receptor are consistent with the steric sensitivity of F6.51
and F6.52; these residues contact each other with a specific geom-
etry (Fig. 2).
A completely different pattern is seen with F3.28 and F5.47 in
the D2 receptor. At both sites, Cha is only minimally different
from wild type. Clearly, aromaticity is not a critical feature of the
side chains at these sites. Instead, hydrophobicity is probably the
key determinant.
Given that a large number of ACh-binding and R-N(CH3)3-
binding sites employ cation– interactions (24, 25, 44), and the fact
that position 6.48 of the M2 receptor is also a Trp, one might have
expected to find a cation– interaction atW6.48 of theM2 receptor.
However, that is clearly not the case. The data of Table 1 and Fig.
4A do not support a straightforward cation– interaction at this
site. Mutations at W7.40, another aromatic that is thought to be
near the agonist-binding site, produced similar data. Given the
unusual nature of the fluorination plots of Fig. 4A, we hesitate to
ascribe a specific role to these residues.
The third site considered for the M2 receptor, W3.28, was
especially susceptible to distorted results frommisacylated suppres-
sor tRNA, as evidenced by the large current observed in experi-
ments in which we injected tRNA without a chemically appended
amino acid. As such, we cannot state with confidence what role this
residue might play. We note that previous experiments have shown
that the amino acid incorporated by misacylation of the THG73
tRNA is most likely Gln (45). If that is the case here, the mere
10-fold shift in EC50 for what is effectively a W3.28Gln mutation is
too small to be consistent with a cation– interaction.We also note
thatmore recently developed tRNAs that are less prone to acylation
may allow study of the W3.28 site (45, 46).
Materials and Methods
Molecular Biology. In these experiments, the cDNA forGoAwas in apCI plasmid,
GIRK1 andGIRK4were in pBSMXTplasmids, D2 receptor (human long form) and
RGS4 were in the pcDNA3.1 plasmid, and the human M2 receptor was in the
pGEM3 plasmid. Plasmids were linearized with the appropriate restriction en-
zymes (GoA with ClaI, the GIRK plasmids with SalI, D2DR with XhoI, RGS4 with
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Fig. 5. Calculated electrostatic potential surfaces (eps) for ACh and dopamine.
Color represents relative electrostatic potential, with blue asmost positive (limit,
150kcal/mol), and redas least positive (limit,13kcal/mol). Also shownare the
structures of each molecule, as well as arrows from a carbon attached to the
ammoniumN to the corresponding carbon in the eps, showing the similarities in
potential.
Fig. 6. A hypothetical dockingmode for dopamine in the D2 receptor. Shown
are W6.48 (Lower Left), dopamine (Center), and D3.32 (Upper Right). The side
chainofW6.48hasbeen rotated fromthat seen inPDB IDcode2RH1,asdiscussed
in text. In the orientation, the dopamine hydroxyls are positioned to enable
hydrogen bonding to serine residues on helix 5 (pink).
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StuI, and the M2AChR with HindIII). The mRNA was prepared by in vitro runoff
transcription using the Ambion T7 mMessage mMachine kit for all of the con-
structs except for GIRK1 and GIRK4, which required the T3 kits. For unnatural
amino acid mutants, the site of interest was mutated to the TAG stop codon by
standard means, verified by sequencing through both strands.
Oocyte Preparation andRNA Injection. StageV-VIoocytesofXenopus laeviswere
harvested and injected with RNAs as described previously (47). Typical oocyte
injection volumeswere 50 nL per cell forM2 receptor and 100 nL for D2 receptor
experiments; doubly injected oocytes received 50-nL and 100-nL injections, re-
spectively, at each injection session. Synthetic amino acids, which were conju-
gated to the dinucleotide dCA and ligated to truncated 74-nt tRNA as described
previously, were deprotected via a 1-kW xenon lamp for 5min by usingWG-335
and UG-11 filters to remove the 6-nitroveratryloxycarbonyl protecting group.
Injectionmixtureconcentrationsweretypicallymadesuchthata1:1combination
of an mRNA mixture solution and a volume of deprotected tRNA yielded the
appropriate concentrations. Wild-type recovery conditions (injecting tRNA with
the native amino acid) were injected alongsidemutant conditions to control for
data variability. Misacylation was assessed at every site of unnatural amino acid
incorporation through the injectionof74-nt THG73 ligated todCA (THG73-dCA).
Electrophysiology. Oocyte recordings were made in 2-electrode voltage clamp
mode by using the OpusXpress 6000A (Axon Instruments). Recording buffers
wereND96 (96mMNaCl, 2mMKCl, 1mMMgCl2, 5mMHepes, and1.8mMCaCl2,
pH7.5)andhigh-Kringer (96mMNaCl,24mMKCl,1mMMgCl2,5mMHepes,and
1.8mMCaCl2, pH 7.5). Solution flow rates were 2mL/min; drug application flow
rates were 4 mL/min for the M2 receptor and 2.5 mL/min for the D2 receptor
experiments. Initial holdingpotentialwas60mV.Datawere sampledat 125Hz
and filtered at 50 Hz. The ND96 prewash lasted 10 s; the high-K application for
basal currents lasted 50 s; drug applications were 15 s in duration for the M2
receptor and 25 s for the D2 receptor; the high-K and ND96 washings were 45 s
and 90 s in duration, respectively. Acetylcholine chloride and dopamine were
purchased from Sigma–Aldrich/RBI. All drugs were prepared in sterile distilled,
de-ionized water for dilution into high-K ringer. Dose–response relations were
fitted to theHill equation, INorm 1/[1EC50/A)]nH, where INorm is the normalized
current peak at [agonist]  A; EC50 is the concentration of agonist that elicits a
half-maximum response; and nH is the Hill coefficient. The cEC50 values were
obtained by fitting a single cell’s INorm data to the Hill equation, whereas EC50
values were obtained by averaging the INorm values for each cell at a given dose
and fitting those average INorm data to the Hill equation. Statistical calculations
were performed by using Origin 7.0 (Origin Lab), MiniTab (MiniTab), or Excel
(Microsoft).
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